Acknowledgement
This study was supported by Huzhou Municipal Science and Technology Bureau Public Welfare Application Research Project under Grant Numbers (2021GZB12, 2021GYB54, 2019GZ40), Zhejiang Medicine and Health Science and Technology Project under Grant Numbers (2020RC118, 2021KY1097).
References
- Ammirati AL (2020) Chronic kidney disease. Rev Assoc Med Brasile 66:s03-s09. https://doi.org/10.1590/1806-9282.66.S1.3
- Chillon JM, Brazier F, Bouquet P, Massy ZA (2014) Neurological disorders in a murine model of chronic renal failure. Toxins 6:180-193. https://doi.org/10.3390/toxins6010180
- Chelluboina B, Vemuganti R (2019) Chronic kidney disease in the pathogenesis of acute ischemic stroke. J Cerebral Blood Flow Metab Off J Int Soc Cerebral Blood Flow Metab 39:1893-1905. https://doi.org/10.1177/0271678x19866733
- Gadalean F, Simu M, Parv F, Vorovenci R, Tudor R, Schiller A et al (2017) The impact of acute kidney injury on in-hospital mortality in acute ischemic stroke patients undergoing intravenous thrombolysis. PLoS One 12:e0185589. https://doi.org/10.1371/journal.pone.0185589
- Ter Maaten JM, Damman K, Verhaar MC, Paulus WJ, Duncker DJ, Cheng C et al (2016) Connecting heart failure with preserved ejection fraction and renal dysfunction: the role of endothelial dysfunction and inflammation. Eur J Heart Fail 18:588-598. https://doi.org/10.1002/ejhf.497
- Eldehni MT, Odudu A, McIntyre CW (2019) Brain white matter microstructure in end-stage kidney disease, cognitive impairment, and circulatory stress. Hemodial Int Symp Home Hemodial 23:356-365. https://doi.org/10.1111/hdi.12754
- Wyld M, Webster AC (2021) Chronic kidney disease is a risk factor for stroke. J Stroke Cerebrovasc Dis Off J Natl Stroke Assoc 30:105730. https://doi.org/10.1016/j.jstrokecerebrovasdis.2021.105730
- Kim YR, Kim HN, Hong KW, Shin HK, Choi BT (2016) Antidepressant effects of phosphodiesterase 3 inhibitor cilostazol in chronic mild stress-treated mice after ischemic stroke. Psychopharmacology 233:1055-1066. https://doi.org/10.1007/s00213-015-4185-6
- Toda Y, Katsura K, Saito M, Inaba T, Sakurazawa M, Katayama Y (2014) The effect of cilostazol and aspirin pre-treatment against subsequent transient focal cerebral ischemia in rat. Neurol Res 36:1011-1019. https://doi.org/10.1179/1743132814y.0000000389
- El-Abhar H, Abd El Fattah MA, Wadie W, El-Tanbouly DM (2018) Cilostazol disrupts TLR-4, Akt/GSK-3β/CREB, and IL-6/JAK-2/STAT-3/SOCS-3 crosstalk in a rat model of Huntington's disease. PLoS One 13:e0203837. https://doi.org/10.1371/journal.pone.0203837
- Li J, Xiang X, Gong X, Shi Y, Yang J, Xu Z (2017) Cilostazol protects mice against myocardium ischemic/reperfusion injury by activating a PPARγ/JAK2/STAT3 pathway. Biomed Pharmacother Biomed Pharmacother 94:995-1001. https://doi.org/10.1016/j.biopha.2017.07.143
- Ghosh SS, Krieg RJ, Sica DA, Wang R, Fakhry I, Gehr T (2009) Cardiac hypertrophy in neonatal nephrectomized rats: the role of the sympathetic nervous system. Pediatric Nephrol (Berlin) 24:367-377. https://doi.org/10.1007/s00467-008-0978-8
- Ghosh SS, Massey HD, Krieg R, Fazelbhoy ZA, Ghosh S, Sica DA et al (2009) Curcumin ameliorates renal failure in 5/6 nephrectomized rats: role of inflammation. Am J Physiol Renal Physiol 296:F1146-F1157. https://doi.org/10.1152/ajprenal.90732.2008
- Deng Y, Shi C, Gu Y, Yang N, Xu M, Xu T et al (2020) A study of optimal concentration range and time window of sevoflurane preconditioning for brain protection in MCAO rats. BMC Anesthesiol 20:78. https://doi.org/10.1186/s12871-020-00984-1
- Chancharoenthana W, Leelahavanichkul A, Taratummarat S, Wongphom J, Tiranathanagul K, Eiam-Ong S (2017) Cilostazol attenuates intimal hyperplasia in a mouse model of chronic kidney disease. PLoS One 12:e0187872. https://doi.org/10.1371/journal.pone.0187872
- Lee WC, Chen HC, Wang CY, Lin PY, Ou TT, Chen CC et al (2010) Cilostazol ameliorates nephropathy in type 1 diabetic rats involving improvement in oxidative stress and regulation of TGFBeta and NF-kappaB. Biosci Biotechnol Biochem 74:1355-1361. https://doi.org/10.1271/bbb.90938
- Drozdz D, Kwinta P, Sztefko K, Kordon Z, Drozdz T, Latka M et al (2016) Oxidative stress biomarkers and left ventricular hypertrophy in children with chronic kidney disease. Oxid Med Cell Longev 2016:7520231. https://doi.org/10.1155/2016/7520231
- Chien SJ, Lin IC, Hsu CN, Lo MH, Tain YL (2015) Homocysteine and arginine-to-asymmetric dimethylarginine ratio associated with blood pressure abnormalities in children with early chronic kidney disease. Circ J 79:2031-2037. https://doi.org/10.1253/circj.CJ-15-0412
- Mihai S, Codrici E, Popescu ID, Enciu AM, Rusu E, Zilisteanu D et al (2016) Proteomic biomarkers panel: new insights in chronic kidney disease. Dis Markers 2016:3185232. https://doi.org/10.1155/2016/3185232
- Saeed ZM, Khattab MI, Khorshid NE, Salem AE (2022) Ellagic acid and cilostazol ameliorate amikacin-induced nephrotoxicity in rats by downregulating oxidative stress, inflammation, and apoptosis. PLoS One 17:e0271591. https://doi.org/10.1371/journal.pone.0271591
- Jabbari B, Vaziri ND (2018) The nature, consequences, and management of neurological disorders in chronic kidney disease. Hemodial Int Symp Home Hemodial 22:150-160. https://doi.org/10.1111/hdi.12587
- Kolachalama VB, Shashar M, Alousi F, Shivanna S, Rijal K, Belghasem ME et al (2018) Uremic solute-aryl hydrocarbon receptortissue factor axis associates with thrombosis after vascular injury in humans. J Am Soc Nephrol 29:1063-1072. https://doi.org/10.1681/asn.2017080929
- Jing W, Jabbari B, Vaziri ND (2018) Uremia induces upregulation of cerebral tissue oxidative/inflammatory cascade, down-regulation of Nrf2 pathway and disruption of blood brain barrier. Am J Transl Res 10:2137-2147
- Assem M, Lando M, Grissi M, Kamel S, Massy ZA, Chillon JM et al (2018) The impact of uremic toxins on cerebrovascular and cognitive disorders. Toxins 10:1. https://doi.org/10.3390/toxins10070303
- von Heesen M, Muller S, Keppler U, Strowitzki MJ, Scheuer C, Schilling MK et al (2015) Preconditioning by cilostazol protects against cold hepatic ischemia-reperfusion injury. Ann Transpl 20:160-168. https://doi.org/10.12659/aot.893031
- Horai S, Nakagawa S, Tanaka K, Morofuji Y, Couraud PO, Deli MA et al (2013) Cilostazol strengthens barrier integrity in brain endothelial cells. Cell Mol Neurobiol 33:291-307. https://doi.org/10.1007/s10571-012-9896-1
- Li J, Xiang X, Xu H, Shi Y (2019) Cilostazol promotes angiogenesis and increases cell proliferation after myocardial ischemia-reperfusion injury through a cAMP-dependent mechanism. Cardiovasc Eng Technol 10:638-647. https://doi.org/10.1007/s13239-019-00435-0
- Jiang X, Guo CX, Zeng XJ, Li HH, Chen BX, Du FH (2015) A soluble receptor for advanced glycation end-products inhibits myocardial apoptosis induced by ischemia/reperfusion via the JAK2/STAT3 pathway. Apoptosis Int J Programmed Cell Death 20:1033-1047. https://doi.org/10.1007/s10495-015-1130-4
- Zhang Z, Pan Y, Zhao Y, Ren M, Li Y, Lu G et al (2021) Delphinidin modulates JAK/STAT3 and MAPKinase signaling to induce apoptosis in HCT116 cells. Environ Toxicol 36:1557-1566. https://doi.org/10.1002/tox.23152